0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sepsis Diagnostic Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-11D6280
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Sepsis Diagnostic Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sepsis Diagnostic Market Research Report 2024

Code: QYRE-Auto-11D6280
Report
August 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sepsis Diagnostic Market Size

The global Sepsis Diagnostic market was valued at US$ 352.1 million in 2023 and is anticipated to reach US$ 502.7 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.

Sepsis Diagnostic Market

Sepsis Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sepsis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Diagnostic.

Report Scope

The Sepsis Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sepsis Diagnostic Market Report

Report Metric Details
Report Name Sepsis Diagnostic Market
Accounted market size in 2023 US$ 352.1 million
Forecasted market size in 2030 US$ 502.7 million
CAGR 5.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Hospitals
  • Pathology & Reference Laboratories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bruker (US), CytoSorbents (US), EKF (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), bioMerieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), Abbott (US)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sepsis Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sepsis Diagnostic Market growing?

Ans: The Sepsis Diagnostic Market witnessing a CAGR of 5.2% during the forecast period 2024-2030.

What is the Sepsis Diagnostic Market size in 2030?

Ans: The Sepsis Diagnostic Market size in 2030 will be US$ 502.7 million.

Who are the main players in the Sepsis Diagnostic Market report?

Ans: The main players in the Sepsis Diagnostic Market are Bruker (US), CytoSorbents (US), EKF (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), bioMerieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), Abbott (US)

What are the Application segmentation covered in the Sepsis Diagnostic Market report?

Ans: The Applications covered in the Sepsis Diagnostic Market report are Hospitals, Pathology & Reference Laboratories

What are the Type segmentation covered in the Sepsis Diagnostic Market report?

Ans: The Types covered in the Sepsis Diagnostic Market report are Laboratory Tests, Point-of-care Tests

Recommended Reports

Diagnostics Markets

Infectious Disease Diagnostics

Cancer & Specialized Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Laboratory Tests
1.2.3 Point-of-care Tests
1.3 Market by Application
1.3.1 Global Sepsis Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2019-2030)
2.2 Sepsis Diagnostic Growth Trends by Region
2.2.1 Global Sepsis Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sepsis Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Sepsis Diagnostic Market Dynamics
2.3.1 Sepsis Diagnostic Industry Trends
2.3.2 Sepsis Diagnostic Market Drivers
2.3.3 Sepsis Diagnostic Market Challenges
2.3.4 Sepsis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostic Players by Revenue
3.1.1 Global Top Sepsis Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostic Revenue
3.4 Global Sepsis Diagnostic Market Concentration Ratio
3.4.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2023
3.5 Sepsis Diagnostic Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostic Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostic Breakdown Data by Type
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2025-2030)
5 Sepsis Diagnostic Breakdown Data by Application
5.1 Global Sepsis Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sepsis Diagnostic Market Size (2019-2030)
6.2 North America Sepsis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sepsis Diagnostic Market Size by Country (2019-2024)
6.4 North America Sepsis Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2019-2030)
7.2 Europe Sepsis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sepsis Diagnostic Market Size by Country (2019-2024)
7.4 Europe Sepsis Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Sepsis Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sepsis Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Sepsis Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostic Market Size (2019-2030)
9.2 Latin America Sepsis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sepsis Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Sepsis Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Sepsis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sepsis Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Sepsis Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker (US)
11.1.1 Bruker (US) Company Detail
11.1.2 Bruker (US) Business Overview
11.1.3 Bruker (US) Sepsis Diagnostic Introduction
11.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.1.5 Bruker (US) Recent Development
11.2 CytoSorbents (US)
11.2.1 CytoSorbents (US) Company Detail
11.2.2 CytoSorbents (US) Business Overview
11.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
11.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.2.5 CytoSorbents (US) Recent Development
11.3 EKF (US)
11.3.1 EKF (US) Company Detail
11.3.2 EKF (US) Business Overview
11.3.3 EKF (US) Sepsis Diagnostic Introduction
11.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.3.5 EKF (US) Recent Development
11.4 T2 Biosystems (US)
11.4.1 T2 Biosystems (US) Company Detail
11.4.2 T2 Biosystems (US) Business Overview
11.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
11.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.4.5 T2 Biosystems (US) Recent Development
11.5 Luminex (US)
11.5.1 Luminex (US) Company Detail
11.5.2 Luminex (US) Business Overview
11.5.3 Luminex (US) Sepsis Diagnostic Introduction
11.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.5.5 Luminex (US) Recent Development
11.6 Thermo Fisher Scientific (US)
11.6.1 Thermo Fisher Scientific (US) Company Detail
11.6.2 Thermo Fisher Scientific (US) Business Overview
11.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
11.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.6.5 Thermo Fisher Scientific (US) Recent Development
11.7 bioMerieux (France)
11.7.1 bioMerieux (France) Company Detail
11.7.2 bioMerieux (France) Business Overview
11.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
11.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2019-2024)
11.7.5 bioMerieux (France) Recent Development
11.8 Danaher (US)
11.8.1 Danaher (US) Company Detail
11.8.2 Danaher (US) Business Overview
11.8.3 Danaher (US) Sepsis Diagnostic Introduction
11.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.8.5 Danaher (US) Recent Development
11.9 Becton, Dickinson and Company (US)
11.9.1 Becton, Dickinson and Company (US) Company Detail
11.9.2 Becton, Dickinson and Company (US) Business Overview
11.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
11.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.9.5 Becton, Dickinson and Company (US) Recent Development
11.10 Roche (Switzerland)
11.10.1 Roche (Switzerland) Company Detail
11.10.2 Roche (Switzerland) Business Overview
11.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
11.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2019-2024)
11.10.5 Roche (Switzerland) Recent Development
11.11 Abbott (US)
11.11.1 Abbott (US) Company Detail
11.11.2 Abbott (US) Business Overview
11.11.3 Abbott (US) Sepsis Diagnostic Introduction
11.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2019-2024)
11.11.5 Abbott (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Laboratory Tests
    Table 3. Key Players of Point-of-care Tests
    Table 4. Global Sepsis Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Sepsis Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Sepsis Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Sepsis Diagnostic Market Share by Region (2019-2024)
    Table 8. Global Sepsis Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Sepsis Diagnostic Market Share by Region (2025-2030)
    Table 10. Sepsis Diagnostic Market Trends
    Table 11. Sepsis Diagnostic Market Drivers
    Table 12. Sepsis Diagnostic Market Challenges
    Table 13. Sepsis Diagnostic Market Restraints
    Table 14. Global Sepsis Diagnostic Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Sepsis Diagnostic Market Share by Players (2019-2024)
    Table 16. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2023)
    Table 17. Ranking of Global Top Sepsis Diagnostic Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostic Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Sepsis Diagnostic Product Solution and Service
    Table 21. Date of Enter into Sepsis Diagnostic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Sepsis Diagnostic Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Sepsis Diagnostic Revenue Market Share by Type (2019-2024)
    Table 25. Global Sepsis Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Sepsis Diagnostic Revenue Market Share by Type (2025-2030)
    Table 27. Global Sepsis Diagnostic Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Sepsis Diagnostic Revenue Market Share by Application (2019-2024)
    Table 29. Global Sepsis Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Sepsis Diagnostic Revenue Market Share by Application (2025-2030)
    Table 31. North America Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Sepsis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Sepsis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Sepsis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Sepsis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Sepsis Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Sepsis Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Sepsis Diagnostic Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Sepsis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Sepsis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Sepsis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Sepsis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Bruker (US) Company Detail
    Table 47. Bruker (US) Business Overview
    Table 48. Bruker (US) Sepsis Diagnostic Product
    Table 49. Bruker (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 50. Bruker (US) Recent Development
    Table 51. CytoSorbents (US) Company Detail
    Table 52. CytoSorbents (US) Business Overview
    Table 53. CytoSorbents (US) Sepsis Diagnostic Product
    Table 54. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 55. CytoSorbents (US) Recent Development
    Table 56. EKF (US) Company Detail
    Table 57. EKF (US) Business Overview
    Table 58. EKF (US) Sepsis Diagnostic Product
    Table 59. EKF (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 60. EKF (US) Recent Development
    Table 61. T2 Biosystems (US) Company Detail
    Table 62. T2 Biosystems (US) Business Overview
    Table 63. T2 Biosystems (US) Sepsis Diagnostic Product
    Table 64. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 65. T2 Biosystems (US) Recent Development
    Table 66. Luminex (US) Company Detail
    Table 67. Luminex (US) Business Overview
    Table 68. Luminex (US) Sepsis Diagnostic Product
    Table 69. Luminex (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 70. Luminex (US) Recent Development
    Table 71. Thermo Fisher Scientific (US) Company Detail
    Table 72. Thermo Fisher Scientific (US) Business Overview
    Table 73. Thermo Fisher Scientific (US) Sepsis Diagnostic Product
    Table 74. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 75. Thermo Fisher Scientific (US) Recent Development
    Table 76. bioMerieux (France) Company Detail
    Table 77. bioMerieux (France) Business Overview
    Table 78. bioMerieux (France) Sepsis Diagnostic Product
    Table 79. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 80. bioMerieux (France) Recent Development
    Table 81. Danaher (US) Company Detail
    Table 82. Danaher (US) Business Overview
    Table 83. Danaher (US) Sepsis Diagnostic Product
    Table 84. Danaher (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 85. Danaher (US) Recent Development
    Table 86. Becton, Dickinson and Company (US) Company Detail
    Table 87. Becton, Dickinson and Company (US) Business Overview
    Table 88. Becton, Dickinson and Company (US) Sepsis Diagnostic Product
    Table 89. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 90. Becton, Dickinson and Company (US) Recent Development
    Table 91. Roche (Switzerland) Company Detail
    Table 92. Roche (Switzerland) Business Overview
    Table 93. Roche (Switzerland) Sepsis Diagnostic Product
    Table 94. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 95. Roche (Switzerland) Recent Development
    Table 96. Abbott (US) Company Detail
    Table 97. Abbott (US) Business Overview
    Table 98. Abbott (US) Sepsis Diagnostic Product
    Table 99. Abbott (US) Revenue in Sepsis Diagnostic Business (2019-2024) & (US$ Million)
    Table 100. Abbott (US) Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sepsis Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Sepsis Diagnostic Market Share by Type: 2023 VS 2030
    Figure 3. Laboratory Tests Features
    Figure 4. Point-of-care Tests Features
    Figure 5. Global Sepsis Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Sepsis Diagnostic Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Pathology & Reference Laboratories Case Studies
    Figure 9. Sepsis Diagnostic Report Years Considered
    Figure 10. Global Sepsis Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Sepsis Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Sepsis Diagnostic Market Share by Region: 2023 VS 2030
    Figure 13. Global Sepsis Diagnostic Market Share by Players in 2023
    Figure 14. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2023
    Figure 16. North America Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Sepsis Diagnostic Market Share by Country (2019-2030)
    Figure 18. United States Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Sepsis Diagnostic Market Share by Country (2019-2030)
    Figure 22. Germany Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Sepsis Diagnostic Market Share by Region (2019-2030)
    Figure 30. China Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Sepsis Diagnostic Market Share by Country (2019-2030)
    Figure 38. Mexico Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Sepsis Diagnostic Market Share by Country (2019-2030)
    Figure 42. Turkey Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Sepsis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Bruker (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 45. CytoSorbents (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 46. EKF (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 47. T2 Biosystems (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 48. Luminex (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 49. Thermo Fisher Scientific (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 50. bioMerieux (France) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 51. Danaher (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 52. Becton, Dickinson and Company (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 53. Roche (Switzerland) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 54. Abbott (US) Revenue Growth Rate in Sepsis Diagnostic Business (2019-2024)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension